GlassScriptPhysician profile
Samuel D Goos
NPI 1548240039
$1,337.84
in general payments reported to CMS, 2019-2025
17 companies · $712 in 2025
The $712 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.28 · 2022: $200 · 2023: $64.17 · 2024: $342 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $166.12 | 2025 | Otezla |
| Abbvie INC. | $137.01 | 2022-2025 | |
| Allergan, INC. | $117.84 | 2022 | |
| Ucb, INC. | $115.05 | 2024-2025 | Bimzelx |
| Janssen Biotech, INC. | $110.65 | 2024-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $99.85 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $96.96 | 2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $82.52 | 2019-2025 | Nemluvio, Aklief |
| Incyte Corporation | $72.45 | 2022-2023 | Opzelura |
| Strata Skin Sciences, INC. | $69.87 | 2023-2025 | Xtrac |
| Novartis Pharmaceuticals Corporation | $52.93 | 2025 | |
| Leo Pharma INC. | $52.81 | 2025 | Anzupgo, Adbry |
| Arcutis Biotherapeutics, INC. | $48.88 | 2024 | Zoryve |
| Lilly USA, LLC | $47.67 | 2024 | Ebglyss, Taltz, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $29.13 | 2024 | Sotyktu |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.10 | 2025 | |
| Botanix Sb INC | $19.00 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Goos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.